ImageneBio Inc (IMA) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

ImageneBio Inc (IMA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $66.9M, listed on NASDAQ, employing roughly 10 people, carrying a beta of 0.74 to the broader market. Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis Led by Kristin Yarema, public since 1998-02-27.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for IMA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →